Goodpath published an Innovation Briefing webinar on GLP-1 misuse and eating disorders featuring Dr. James Lyda, Ph.D.
Published
Signal category
Research & Knowledge
Quote
“In this clip from our recent Innovation Briefing webinar on GLP-1 misuse and eating disorders, Dr. James Lyda, Ph.D. explains why eating disorder screening in weight management programs has to be followed by structured clinical assessments and ongoing mental health treatment”
— Goodpath team
Company
Goodpath
Integrative care for weight management, obesity, and cardiometabolic health.
- Industry
- Hospitals and Health Care
- Location
- Cambridge, US
- Company size
- 83 employees
Goodpath provides integrative, whole person care that treats obesity, weight and cardiometabolic health alongside the comorbidities driving it - MSK pain, mental health, sleep, and digestive health - with clinically supervised GLP-1 support built in. Every member gets physician oversight, unlimited clinical coaching, and behavioral health tools included, whether through Goodpath WeightRx (our Direct-to-Employer model with transparent, pass-through manufacturer pricing, no PBM, no rebates, no spread) or a self-pay option. The result, verified by independent actuarial analysis of real claims data: $2,292 in total cost of care savings per member per year.
Founded 2019